ASHG:How UK Biobank is enabling scientific discoveries in population health

1201 South Figueroa Street,Los Angeles CA 90015

26 October, 2022

Description

Join us at ASHG in Los Angeles on the 26 October for a stimulating series of talks about how UK Biobank, a large-scale biomedical database and research resource, is enabling scientific discoveries into the genetic and non-genetic determinants of human disease. Presentations will focus on how data on genomics, biomarkers (including metabolomics and proteomics) and multi-modal imaging are enabling research to advance our understanding of the treatment and prevention of disease. You will also get the chance to understand how UK Biobank’s unique access model can enable your research goals through accessing over 25 petabytes of data in the cloud from anywhere in the world via the UK Biobank Research Analysis Platform (RAP). Hear from expert speakers on how we can help accelerate your research into the genetic and non-genetic determinants of disease. 07:00 – 07:05 - Session Chair: Professor Marylyn Ritchie, Director, Institute for Biomedical Informatics, Penn Centre for Precision Medicine 07:05 – 07:10 - Multi-omics in UK Biobank: Associate Professor Ben Lacey, UK Biobank Epidemiology Group Lead 07:10 – 07:15 - Applications of whole genome sequencing in pharmaceutical development: Professor Mary Helen Black, Foresite Labs 07:15 - 07:20 Applications of whole genome sequencing in pharmaceutical development: Dr Dongnhu Truong, Janssen 07:20 – 07:25 - Precision phenotyping with abdominal MRI in the UK Biobank: Professor Madeleine Cule, Associate Director Data Science, Calico 07:25 – 07:30 - The case for methylation data: Dr Steve Horvath, Altos San Diego Institute of Science 07:30 – 07:35 - Analysing UK Biobank sequencing data in the RAP: Mr Mahesh Pancholi, Chief Information Officer, UK Biobank 07:35 – 08:00 - Panel Q&A Breakfast refreshments provided. You need to be a registered attendee to ASHG 2022 to attend the UK Biobank session in the Convention Centre.